Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients?

Is there an association between lymph node size and hyperprogression in immunotherapy-treated patients?

Background: Hyperprogressive disease (HPD) can be described as an accelerated increase in the growth rate of tumors combined with rapid clinical deterioration observed in a subset of cancer patients undergoing immunotherapy, specifically with immune checkpoint inhibitors (ICIs). The reported inciden...

Full description

Bibliographic Details
Main Authors: Alkader Mohammad S., Altaha Rashed Z., Jabali Eslam H., Attieh Ola A., Matalqa Ala’ W.
Format: Article
Language:English
Published: Sciendo 2024-03-01
Series:Romanian Journal of Internal Medicine
Subjects:
hyperprogressive disease
immunotherapy
lymph nodes
renal cell carcinoma
risk factors
Online Access:https://doi.org/10.2478/rjim-2023-0025

Internet

https://doi.org/10.2478/rjim-2023-0025

Similar Items